Instil Bio (formerly Immetacyte, Cellular Therapeutics) is an immuno-oncology company that specializes in cell therapies. Its technology platform is based on the use of tumor-infiltrating lymphocytes (TILs), T-cells isolated from the patient’s tumor that can recognize and destroy cancer. The company leverages TIL technology to treat metastatic melanoma patients.